Survival rates and patterns of care for patients diagnosed with supratentorial low‐grade gliomas

Detailed population‐based estimates of long‐term survival as well as patterns of care for patients with low‐grade gliomas examined by age at diagnosis, gender, and race have not been widely available.

[1]  M. J. van den Bent.  Advances in the biology and treatment of oligodendrogliomas , 2004, Current opinion in neurology.

[2]  D. Louis,et al.  Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. , 1998, Journal of the National Cancer Institute.

[3]  M. Bent.  Advances in the biology and treatment of oligodendrogliomas. , 2004 .

[4]  H. Bloom,et al.  Low grade glioma of the cerebral hemispheres in adults: a retrospective analysis of 88 cases. , 1990, International journal of radiation oncology, biology, physics.

[5]  S. Brem,et al.  Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. , 1998, Journal of neurosurgery.

[6]  K. Hess,et al.  Glutathione S-Transferase Polymorphisms and Survival in Primary Malignant Glioma , 2004, Clinical Cancer Research.

[7]  Patricio C. Gargollo,et al.  Intraoperative magnetic resonance imaging: considerations for the operating room of the future , 2001, Journal of Clinical Neuroscience.

[8]  L. Deangelis,et al.  Long-term outcome of low-grade oligodendroglioma and mixed glioma , 2000, Neurology.

[9]  B. Scheithauer,et al.  Supratentorial gliomas: a comparative study by grade and histologic type , 1997, Journal of Neuro-Oncology.

[10]  R. Makuch,et al.  Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. , 1996, Neurosurgery.

[11]  M. Berger,et al.  Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base. , 1999, Neuro-oncology.

[12]  D. Bigner,et al.  Consistency of Primary Brain Tumor Diagnoses and Codes in Cancer Surveillance Systems , 2004, Neuroepidemiology.

[13]  M. Berger,et al.  Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. , 2001, Journal of neurosurgery.

[14]  R. Mirimanoff,et al.  MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.

[15]  A. Peraud,et al.  Clinical Outcome of Supratentorial Astrocytoma WHO Grade II , 1998, Acta Neurochirurgica.

[16]  A. Bricolo,et al.  Prognostic factors in low-grade supratentorial astrocytomas: a uni-multivariate statistical analysis in 76 surgically treated adult patients. , 1995, Surgical neurology.

[17]  Faith Davis,et al.  Brain tumor survival: Results from the National Cancer Data Base , 1998, Journal of Neuro-Oncology.

[18]  G. Strauß,et al.  Clinical results in MR-guided therapy for malignant gliomas. , 2003, Acta neurochirurgica. Supplement.

[19]  B. Bergquist.  Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit. , 2000, Neurosurgery.

[20]  S. Piantadosi,et al.  Low‐grade cerebral astrocytomas: Survival and quality of life after radiation therapy , 1990, Cancer.

[21]  F. Jolesz,et al.  Survival rates in patients with low‐grade glioma after intraoperative magnetic resonance image guidance , 2005, Cancer.

[22]  F. Davis,et al.  The conditional probability of survival of patients with primary malignant brain tumors , 1999, Cancer.

[23]  M. Scerrati,et al.  Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[24]  D.,et al.  Regression Models and Life-Tables , 2022 .